ドライアイ症候群の世界市場レポート 2024年

ドライアイ症候群市場規模は近年力強く成長しています。2023年の36億8,000万米ドルから2024年には39億6,000万米ドルへ、CAGR7.9％で成長します。

過去の期間に見られた拡大は、ヘルスケアへのアクセスの改善、治療オプションの進歩、薬剤や健康状態の影響、ホルモンの変化の影響、眼科手術の影響などの要因に起因しています。

ドライアイ症候群市場規模は、今後数年間で力強い成長が見込まれます。2028年には年間平均成長率（CAGR）7.2％で52億3,000万米ドルに成長します。予測期間中に拡大が見込まれる背景には、高齢化社会への人口動態の変化、スクリーン使用の普及率上昇、生活習慣の変化、ヘルスケアに対する意識とアクセスの向上、眼科手術の継続的動向、新規治療法の出現などがあります。予測期間中に予想される主な動向には、眼の健康に対する全体的アプローチの採用、眼科医療における人工知能（AI）の統合、遠隔医療と遠隔診察の取り入れ、個別化医療アプローチの採用、認識と教育への重点の高まりなどがあります。

ドライアイ症候群市場の予想される成長は、ドライアイ症候群の有病率の増加によって牽引されると予想されます。ドライアイ症候群に対応した製品や医薬品は、潤滑と潤いを与え、涙の分泌を促進し、涙の質を高め、炎症を抑え、眼表面を保護することを目的としています。例えば、Eyes On Eyecareが2022年3月に実施した調査によると、2022年には3,500万人のアメリカ人がドライアイ（DED）を経験すると予測されており、今後もその頻度は増加するとされています。さらに、UpToDate Inc.によると、2022年に米国で行われた3つの研究のメタアナリシスでは、ドライアイのプール有病率は8.1%と報告されています。したがって、ドライアイ症候群の有病率の上昇は市場の重要な促進要因です。

2023年のドライアイ症候群市場で最大の地域は北米です。アジア太平洋は、予測期間中、世界のドライアイ症候群市場レポートにおいて最も急成長している地域になると予測されています。ドライアイ症候群市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のドライアイ症候群市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 点眼薬
• ジェル
• 液体ワイプ
• 目の軟膏
• その他
• 世界のドライアイ症候群市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• コルチコステロイド
• 人工涙液
• 経口オメガサプリメント
• 潤滑剤
• その他
• 世界のドライアイ症候群市場、疾患タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 蒸発性
• 水性
• 世界のドライアイ症候群市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院・診療所
• 医療研究所
• その他

第7章 地域および国の分析

• 世界のドライアイ症候群市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のドライアイ症候群市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ドライアイ症候群市場の競合情勢
• ドライアイ症候群市場の企業プロファイル
  • Allergan plc
  • Novartis AG
  • Otsuka Pharmaceutical Co. Ltd.
  • Santendo Pharmaceutical Co. Ltd.
  • Sentiss Pharma Pvt. Ltd.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Dry Eye Syndrome Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dry eye syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry eye syndrome? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The dry eye syndrome market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Liquid Drops; Gel; Liquid Wipes; Eye Ointment; Other Products
• 2) By Treatment: Corticosteroids; Artificial Tears; Oral Omega Supplements; Lubricating Agent; Other Treatments
• 3) By Disease Type: Evaporative; Aqueous
• 4) By Distribution Channel: Offline; Online
• 5) By Application: Hospitals And Clinics; Medical Laboratories; Other Applications
• Companies Mentioned: Allergan plc; Novartis AG; Otsuka Pharmaceutical Co. Ltd.; Santendo Pharmaceutical Co. Ltd.; Sentiss Pharma Pvt. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Dry eye syndrome, also known as dry eye illness, is a prevalent condition characterized by insufficient tear production or the generation of poor-quality tears. The condition manifests when the eyes fail to produce an adequate amount of tears, leading to discomfort, irritation, and inflammation.

Products designed to address dry eye syndrome include liquid drops, gel formulations, liquid wipes, eye ointments, and other related solutions. Liquid eye drops, specifically, are fluid formulations applied directly to the eyes to alleviate dryness, provide moisture, and offer lubrication. These drops encompass a variety of treatments, ranging from corticosteroids to artificial tears, oral omega supplements, and lubricating agents. These products are available through both offline and online channels and are employed in the treatment of evaporative and aqueous diseases. They find application in diverse settings, including hospitals, clinics, medical laboratories, and other healthcare facilities.

The dry eye syndrome market research report is one of a series of new reports from The Business Research Company that provides dry eye syndrome market statistics, including dry eye syndrome industry global market size, regional shares, competitors with a dry eye syndrome market share, detailed dry eye syndrome market segments, market trends, and opportunities, and any further data you may need to thrive in the dry eye syndrome industry. This dry eye syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry eye syndrome market size has grown strongly in recent years. It will grow from $3.68 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%.

The expansion observed in the historical period can be attributed to factors such as improved access to healthcare, advancements in treatment options, the influence of medications and health conditions, the impact of hormonal changes, and the consequences of ocular surgery.

The dry eye syndrome market size is expected to see strong growth in the next few years. It will grow to $5.23 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The anticipated expansion in the forecast period can be attributed to demographic shifts toward an aging population, the rising prevalence of screen usage, changes in lifestyle habits, increased awareness and accessibility to healthcare, ongoing trends in ocular surgery, and the emergence of novel therapies. Major trends expected in the forecast period include adopting a holistic approach to eye health, integrating artificial intelligence (AI) in eye care, the incorporation of telemedicine and remote consultations, adopting a personalized medicine approach, and an increased focus on awareness and education.

The anticipated growth of the dry eye syndrome market is expected to be driven by the increasing prevalence of dry eye syndrome. This condition occurs when the eyes do not produce enough tears, and products and medications designed for dry eye syndrome aim to provide lubrication and moisture, boost tear production, enhance tear quality, reduce inflammation, and protect the ocular surface. For instance, a survey conducted by Eyes On Eyecare in March 2022 revealed that 35 million Americans were projected to experience dry eye disease (DED) in 2022, with a continued increase in frequency. Additionally, a meta-analysis of three US studies in 2022, according to UpToDate Inc., reported an 8.1% pooled prevalence of dry eye. Hence, the rising prevalence of dry eye syndrome is a significant driver for the market.

The growth of the dry eye syndrome market is the expanding aging population. This demographic trend, characterized by a rising proportion of elderly individuals, creates an increased demand for effective treatments and solutions for conditions such as dry eye syndrome. Globally, the World Health Organization projects that by 2030, 1 in 6 people will be 60 or older, and this age group will double to 2.1 billion by 2050. In the UK, data from the UK Parliament's House of Commons Library indicates that by 2043, 24% of the total population (17.4 million people) will consist of seniors. Consequently, the growing aging population becomes a driving force for the dry eye syndrome market.

Product innovation stands out as a prominent trend, with major companies focusing on the development of innovative solutions to maintain their market position. For example, in May 2023, Entod Pharmaceuticals Ltd., an India-based company, introduced Cyclotears eye drops, specifically designed for treating dry eye disease. This pioneering product incorporates self-emulsifying drug delivery system (SEDDS) technology, enhancing the delivery of poorly water-soluble drugs to the ocular region. Cyclotears eye drops utilize cyclodextrin to enhance stability and retention time of the tear film on the eye surface. Some highlighted features include a novel active ingredient, improved retention time, a lubricating effect, and being safe and preservative-free.

Major players in the dry eye syndrome market are directing their efforts towards launching innovative products to address the increasing demand for preservative-free eye drops. An example is Systane, with its Systane Complete Preservative-Free Lubricant Eye Drops added to its innovative portfolio of dry eye products. Alcon, a Switzerland-based ophthalmology company, introduced these eye drops in January 2022 to cater to individuals experiencing dry eyes, a condition resulting from insufficient tear production or rapid tear evaporation. Systane Complete Preservative-Free Lubricant Eye Drops aim to alleviate various dry eye symptoms, providing relief, protection, and hydration.

In June 2022, Novartis AG, a Switzerland-based pharmaceutical corporation, completed the acquisition of Kedalion Therapeutics for an undisclosed amount. This strategic move positions Novartis AG to deliver customer- and patient-centric ophthalmic advancements, particularly for dry eye syndrome, and strengthens its leadership in the rapidly growing ophthalmology market. Kedalion Therapeutics, a US-based clinical-stage ophthalmic drug company, offers a range of products and preventive services for dry eye syndrome.

Major companies operating in the dry eye syndrome market report are Allergan plc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Santendo Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Johnson & Johnson, Alcon Vision LLC, Akorn Operating Company LLC, Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., AbbVie Inc., GlaxoSmithKline plc, I-MED Pharma Inc., Hoffmann-La Roche AG, Acadia Pharmaceuticals Inc., AFT Pharmaceuticals, Horus Pharma, Mitotech, Novaliq GmbH, OASIS Medical, Prestige Consumer Healthcare, VISUfarma, Alimera Science, Auven Therapeutics, Kala Pharmaceuticals Inc., Nicox S.A., Emisphere Technologies Inc., EyeGate Pharmaceuticals Inc., ReVision Therapeutics Inc., Avedro Inc., Itear Medical, Transcend Medical Inc.

North America was the largest region in the dry eye syndrome market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global dry eye syndrome market report during the forecast period. The regions covered in the dry eye syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the dry eye syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The dry eye syndrome market includes revenues earned by entities by providing services such as dry eye diagnosis, treatment of dry eye syndrome, prescribed medications, antibiotics, humidifiers, and protective eyewear. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Dry Eye Syndrome Market Characteristics

3. Dry Eye Syndrome Market Trends And Strategies

4. Dry Eye Syndrome Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Dry Eye Syndrome Market Size and Growth

• 5.1. Global Dry Eye Syndrome Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Dry Eye Syndrome Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Dry Eye Syndrome Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Dry Eye Syndrome Market Segmentation

• 6.1. Global Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Other Products
• 6.2. Global Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Corticosteroids
• Artificial Tears
• Oral Omega Supplements
• Lubricating Agent
• Other Treatments
• 6.3. Global Dry Eye Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Evaporative
• Aqueous
• 6.4. Global Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Medical Laboratories
• Other Applications

7. Dry Eye Syndrome Market Regional And Country Analysis

• 7.1. Global Dry Eye Syndrome Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Dry Eye Syndrome Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Dry Eye Syndrome Market

• 8.1. Asia-Pacific Dry Eye Syndrome Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Dry Eye Syndrome Market

• 9.1. China Dry Eye Syndrome Market Overview
• 9.2. China Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Dry Eye Syndrome Market

• 10.1. India Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Dry Eye Syndrome Market

• 11.1. Japan Dry Eye Syndrome Market Overview
• 11.2. Japan Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Dry Eye Syndrome Market

• 12.1. Australia Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Dry Eye Syndrome Market

• 13.1. Indonesia Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Dry Eye Syndrome Market

• 14.1. South Korea Dry Eye Syndrome Market Overview
• 14.2. South Korea Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Dry Eye Syndrome Market

• 15.1. Western Europe Dry Eye Syndrome Market Overview
• 15.2. Western Europe Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Dry Eye Syndrome Market

• 16.1. UK Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Dry Eye Syndrome Market

• 17.1. Germany Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Dry Eye Syndrome Market

• 18.1. France Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Dry Eye Syndrome Market

• 19.1. Italy Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Dry Eye Syndrome Market

• 20.1. Spain Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Dry Eye Syndrome Market

• 21.1. Eastern Europe Dry Eye Syndrome Market Overview
• 21.2. Eastern Europe Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Dry Eye Syndrome Market

• 22.1. Russia Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Dry Eye Syndrome Market

• 23.1. North America Dry Eye Syndrome Market Overview
• 23.2. North America Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Dry Eye Syndrome Market

• 24.1. USA Dry Eye Syndrome Market Overview
• 24.2. USA Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Dry Eye Syndrome Market

• 25.1. Canada Dry Eye Syndrome Market Overview
• 25.2. Canada Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Dry Eye Syndrome Market

• 26.1. South America Dry Eye Syndrome Market Overview
• 26.2. South America Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Dry Eye Syndrome Market

• 27.1. Brazil Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Dry Eye Syndrome Market

• 28.1. Middle East Dry Eye Syndrome Market Overview
• 28.2. Middle East Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Dry Eye Syndrome Market

• 29.1. Africa Dry Eye Syndrome Market Overview
• 29.2. Africa Dry Eye Syndrome Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Dry Eye Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Dry Eye Syndrome Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Dry Eye Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Dry Eye Syndrome Market Competitive Landscape
• 30.2. Dry Eye Syndrome Market Company Profiles
  • 30.2.1. Allergan plc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Novartis AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Otsuka Pharmaceutical Co. Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Santendo Pharmaceutical Co. Ltd.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Sentiss Pharma Pvt. Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Dry Eye Syndrome Market Competitive Benchmarking

32. Global Dry Eye Syndrome Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Dry Eye Syndrome Market

34. Dry Eye Syndrome Market Future Outlook and Potential Analysis

• 34.1 Dry Eye Syndrome Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Dry Eye Syndrome Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Dry Eye Syndrome Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer